BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25663152)

  • 1. How Well Do the Generic Multi-attribute Utility Instruments Incorporate Patient and Public Views Into Their Descriptive Systems?
    Stevens KJ
    Patient; 2016 Feb; 9(1):5-13. PubMed ID: 25663152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can multi-attribute utility instruments adequately account for subjective well-being?
    Richardson J; Chen G; Khan MA; Iezzi A
    Med Decis Making; 2015 Apr; 35(3):292-304. PubMed ID: 25623064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations.
    Chen G; Ratcliffe J
    Pharmacoeconomics; 2015 Oct; 33(10):1013-28. PubMed ID: 25985933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring the Sensitivity and Construct Validity of 6 Utility Instruments in 7 Disease Areas.
    Richardson J; Iezzi A; Khan MA; Chen G; Maxwell A
    Med Decis Making; 2016 Feb; 36(2):147-59. PubMed ID: 26582319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of QALY weights for QALY calculations: a review of industry submissions requesting listing on the Australian Pharmaceutical Benefits Scheme 2002-4.
    Scuffham PA; Whitty JA; Mitchell A; Viney R
    Pharmacoeconomics; 2008; 26(4):297-310. PubMed ID: 18370565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures.
    Mihalopoulos C; Chen G; Iezzi A; Khan MA; Richardson J
    Br J Psychiatry; 2014 Nov; 205(5):390-7. PubMed ID: 25257063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's disease.
    McGrath C; Rofail D; Gargon E; Abetz L
    Health Qual Life Outcomes; 2010 Feb; 8():23. PubMed ID: 20152041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of the Literature on the Development of Condition-Specific Preference-Based Measures of Health.
    Goodwin E; Green C
    Appl Health Econ Health Policy; 2016 Apr; 14(2):161-83. PubMed ID: 26818198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.
    Richardson G; Manca A
    Health Econ; 2004 Dec; 13(12):1203-10. PubMed ID: 15386669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D Multi-Attribute Utility Instruments in Patients Who Have Previously Undergone Bariatric Surgery.
    Campbell JA; Palmer AJ; Venn A; Sharman M; Otahal P; Neil A
    Patient; 2016 Aug; 9(4):311-22. PubMed ID: 26841910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome measurement in economic evaluation.
    Johannesson M; Jönsson B; Karlsson G
    Health Econ; 1996; 5(4):279-96. PubMed ID: 8880165
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health outcomes in economic evaluation: who should value health?
    Stamuli E
    Br Med Bull; 2011; 97():197-210. PubMed ID: 21285110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health economic studies: an introduction to cost-benefit, cost-effectiveness, and cost-utility analyses.
    Angevine PD; Berven S
    Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S9-15. PubMed ID: 25299265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporating feelings related to the uncertainty about future health in utility measurement.
    Gandjour A
    Health Econ; 2008 Oct; 17(10):1207-13. PubMed ID: 18074407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategic Planning in Population Health and Public Health Practice: A Call to Action for Higher Education.
    Phelps C; Madhavan G; Rappuoli R; Levin S; Shortliffe E; Colwell R
    Milbank Q; 2016 Mar; 94(1):109-25. PubMed ID: 26994711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of differences in EQ-5D and SF-6D utility scores on the acceptability of cost-utility ratios: results across five trial-based cost-utility studies.
    Joore M; Brunenberg D; Nelemans P; Wouters E; Kuijpers P; Honig A; Willems D; de Leeuw P; Severens J; Boonen A
    Value Health; 2010; 13(2):222-9. PubMed ID: 19878492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.
    Shiroiwa T; Saito S; Shimozuma K; Kodama S; Noto S; Fukuda T
    Appl Health Econ Health Policy; 2016 Jun; 14(3):375-85. PubMed ID: 26940671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of social care for adults: developing a preference-weighted measure.
    Netten A; Burge P; Malley J; Potoglou D; Towers AM; Brazier J; Flynn T; Forder J; Wall B
    Health Technol Assess; 2012; 16(16):1-166. PubMed ID: 22459668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.